New research initiative aims to position Australia at the forefront of quantum biotechnology

The University of Queensland has launched a $45 million research initiative to position Australia as a global leader in quantum biotechnology, and tackle some of the world’s biggest challenges.

Editas trades part of Vertex CRISPR therapy licencing rights deal for $57m – Pharmaceutical Technology

CRISPR/Cas9 is a gene-editing technology that allows scientists to precisely cut and modify DNA in living organisms. Credit: Prostock-studio via Shutterstock. Amidst the long-running Cas9

October 6, 2024

Aptose Biosciences secures funds for AML treatment development

Tuspetinib is being analysed for the treatment of acute myeloid leukaemia. Credit: Yomal2233/Shutterstock. Aptose Biosciences has secured a loan of $10m through a facility agreement

September 2, 2024

Novartis used a PRV to speed Kisqali’s latest indication, FDA says

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.